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Abstract 
Objectives: Antiplatelet drugs are used to treat and prevent a wide range of cardiovascular pathologies and/or 
cerebrovascular accidents. Although the use of anticoagulants in dental extractions is highly protocolized, a clear 
control method has not yet been established for antiplatelet drugs. This study is directed at evaluating the clini-
cal consequences of extractions in patients on antiplatelet therapy. Study design: The Oral Health Department of 
the Navarre Health Service-Osasunbidea conducted a trial on 155 patients who underwent dental extractions and 
were receiving antiplatelet therapy. The patients were not requested to interrupt the medication and local measures 
were taken to control potential haemorrhage. Results: No major haemorrhages were reported. One patient had a 
moderate haemorrhage that required emergency care. In the remaining patients the bleeding was controlled with 
local measures. With regard to subsequent bleeding, no differences were observed between the various antiplatelet 
drugs used. The only statistically significant relationship found was between bleeding and the number of teeth 
extracted. Conclusions: It can be concluded that no more than 3 teeth should be removed at any one time, and for 
multiple extractions, the teeth should be adjacent to each other.
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Introduction
Antiplatelet drugs are used to prevent and / or treat 
thromboembolic disorders, which play a key role in 
cardiovascular diseases.  Given the fact that the anti-
aggregant mechanism of action consists in inhibiting 
the platelet function by preventing aggregation, the 
initial phase of  haemostasis (1), use of these drugs can 
make patients more susceptible to haemorrhages. This 
is of vital importance in the daily practice of  dentists, 
particularly when performing surgery, such as dental 
extractions.
In the past, a bleeding time analysis was conducted 
in order to assess the haemorrhage risk level for these 
patients. This test was subsequently replaced by more 
sophisticated ones such as the PFA-100 or the platelet 
aggregation measurement by the impedance method. 
However, as Brenan et al. (1) have indicated, there is no 
analytical test which serves to conclusively evaluate the 
risk of  bleeding  in these patients. At the Oral Health 
Department of the Navarre Health Service - Osasunbi-
dea, we undertook to conduct a study on those patients 
undergoing routine dental extractions and who were also 
receiving antiplatelet therapy. The study was directed at 
monitoring and controlling the patients’ progress and 
their haemorrhagic response to normal dental extrac-
tions, using simple techniques and procedures.
Material and Methods
We monitored the progress of 155 consecutive, patients 
on antiplatelet therapy who underwent dental extractions 
at the Oral Health Department of the Navarre Health 
Service - Osasunbidea. Normal procedures were fol-
lowed for the anaesthesia and dental extractions, which 
were performed by 4 dentists from the Department. An 
intra-alveolar gel plug (Gelatamp®) was then applied to 
the extraction site and a dry gauze was pressed down 
on top. The patient was monitored for 10 minutes and 
was then sent home with a gauze pad on the wound and 
the usual post-extraction written instructions (hold the 
gauze in place with firm pressure for 1 hour, no mouth 
rinsing, liquid or soft cold diet for the first 24 hours, 
etc). After at least 24 hours had elapsed, the patient was 
contacted by phone to investigate how he/she was pro-
gressing and a record was made as to whether the patient 
had experienced any problems and, if so, the particular 
problems reported.
The following was recorded in the data collection note-
book: professional performing the treatment; patient’s 
social security details; age; gender; medical condition 
for which the antiplatelet therapy was prescribed; an-
tiplatelet brand name and dose level; whether or not 
the patient had stopped taking the drug a few days be-
fore the extraction (if so, the number of days involved); 
brand name of the anaesthetic used; amount of anaes-
thetic; anaesthetic technique; number of teeth extracted 
and which teeth involved; type of extraction performed 
(simple, laborious or surgical); post-extraction attitude; 
monitoring after 10 minutes; monitoring by phone 24 
hours later with three possibilities:
a) No problems
b) Still bleeding (with a recommendation for the patient 
to go to the Oral Health Department)
c) Bleeding did occur and had been controlled. This in 
turn was sub-divided into 4 options:
1- Plugging with gauze
2- Plugging with gauze with Amchafibrin®.
3- Mouth rinsing with Amchafibrin®.
4- Visit to accident and emergency (A&E)
The study was approved by the Clinical Research Ethi-
cal Committee of the Navarre Health Service.
The mean age was 68.3 years (C.I. of  95% = 66.6 to 70.1 
years), with a range from 32 to 91 years. 125 patients 
were male (80.6%) and the remaining 30 were female 
(19.2%).
Table 1 shows the principal pathologies for which the 
patients were taking antiplatelet therapy, whilst Tables 
2 and 3 indicate the percentages of use for the different 
antiplatelet drugs and the different products available in 
the market.
Table 1. Pathologies for which the patients were taking anti-
platelet therapy.
Table 2. Antiplatelet drugs percentage of use.
Pathology % of patients
Diabetes (primary prevention) 7.3
Acute coronary syndromes 26.6
Angina 7.3
Fibrillation 4.0
Myocardiopathy 1.6
Coronary angioplasty 2.4
Autocoronary vein graft 0.8
Ischemic cerebral vascular disease 15.3
Peripheral arterial disease 15.3
Other symptoms 19.4
Antiplatelet drug Nº of patients
% of 
patients
Acetylsalicylic acid 118 76.3
Clopidogrel 20 12.8
Ticlopidine 2 1.3
Triflusal 15 9.6
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134 patients continued with their anti-aggregant treat-
ment, whilst the remaining 22 patients interrupted the 
therapy a few days before the extraction, a mean of 4.9 
days before the dental extraction appointment.
In 98.7% of the cases, 1% Ultracaín® was used as an an-
aesthetic, whilst Scandinibsa® was used in the remain-
ing 1.3% cases, the latter being a vasoconstrictor-free 
anaesthetic. An infiltration technique was employed 
in 138 cases and nerve block anaesthesia was used for 
the 17 remaining patients. 69.2% of the patients were 
injected with 2 anaesthetic cartridges (3.6 cm3); 1 car-
tridge was used for 28.8% (1.8 cm3) and an intermediate 
amount of anaesthetic was used for 1.9% of patients (3.3 
cm3).
A total of 222 teeth were extracted from the 155 pa-
tients: 119 anterior teeth (53.8%); 57 premolars (25.8%); 
and 45 molars (20.4%). The upper lateral right incisor 
was the most frequently extracted tooth (13 times), fol-
lowed by the upper right canine (12 times), the lower 
right central incisor, the lower left first premolar and the 
upper left second premolar (Fig. 1).
The mean number of teeth extracted per session was 1.4 
teeth; on 107 occasions only one tooth was extracted; 
on 31 occasions two extractions were made; and on 15 
occasions three extractions were performed, whilst four 
teeth were simultaneously extracted on two occasions.
The dental extraction was simple in 90.4% of patients, 
laborious in 7.1% and surgical in 1.9% of these patients.
The data were compiled in an Excel 2003 spreadsheet 
Table 3. Antiplatelet drug brand percentage of use.
Fig. 1. Teeth extracted and number of extractions.
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Antiplatelet drug Nº of 
patients
% of 
patients
AAS 100® 5 3.2
Adiro 100® 88 56.4
Adiro 300® 18 11.6
Bioplak 125® 1 0.6
Tromalyt 150® 5 3.2
Tromalyt 300® 1 0.6
Iscover 75® 10 6.5
Plavix 75® 10 6.5
Ticlopidine EFG 2 1.3
Disgren® 15 9.7
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and formulas were used to calculate the descriptive sta-
tistics for the cases. The Windows 14.0 SPSS program 
was also used for the analytical statistics, using the  χ2 
test for comparison between proportions, and Fisher’s 
exact test  when the  χ2 test could not be used. The statis-
tical significance was determined when “p” was equal 
to or less than 0.05.
Results
In the check made 10 minutes after extraction, only one 
patient was found to be bleeding, and this was control-
led with a gauze with Amchafibrin®, with no subsequent 
problems. In the phone check made 24 hours later, we 
found that 83.3% of patients had experienced no prob-
lems at all, whilst 16.7% (26 patients) reported “blee-
ding which they had controlled”. Of these 26 patients: 
20 had simply controlled the bleeding by applying and 
pressing down with a fresh, dry gauze; 1 had gone to 
A&E and been given one suture; whilst the other 4 pa-
tients reported as follows:
a) The haemorrhage had stopped by itself.
b) With mouth rinses of water, vinegar and salt.
c) And the same patient reported slight bleeding at night 
on one occasion and, on another occasion, bleeding af-
ter 24 hours, which stopped without plugging the ex-
traction site.
Finally, one patient reported that he had “bled and con-
trolled the bleeding” but made no further comments.
Of the 26 patients that had bled and controlled the bleed-
ing, 3 patients had interrupted the antiplatelet therapy on 
their own decision; they were taking a daily dose of 100 
mg of Acetylsalicylic acid (ASA) which they stopped 
taking, on average, 6 days before the extraction. Two of 
these patients had 3 teeth removed and the other patient 
had just 1 tooth removed.
These 26 patients had the following gender distribution: 
18 male (69.2%) and 8 female (30.8%). Although this 
distribution appears different from the original popula-
tion, no significant difference was found (Fischer’s ex-
act test p=0.093).
The 26 patients who reported on the phone that they had 
bled and controlled the bleeding were taking the fol-
lowing antiplatelet drugs: 22 were taking ASA (84.6% 
of those reporting some haemorrhage), 2 were taking 
clopidogrel (7.7% of these 26 cases) and a further 2 were 
taking triflusal (again 7.7% of the total of 26 cases). This 
distribution has no statistically significant differences 
(χ2=1.483, p=0.686) with the distribution shown in Ta-
ble 2 corresponding to all the patients of this present 
study. Of the 22 patients taking ASA, and who reported 
some haemorrhage, 21 were taking a dose of 100 or 150 
mg/day, whilst a further patient had a higher dose of 
300 mg/day; there were no statistically significant dif-
ferences with regard to the ASA dose level and the pos-
sible haemorrhage (χ2=2.724, p=0.099).
The type of extraction performed on these patients was 
surgical for one case (3.8% of the 26 cases), laborious 
on 2 occasions (7.7%) and simple for the remaining 23 
cases (88.5% of the 26 cases); neither did these results 
give any statistically significant differences (χ2=0.626, 
p=0.731). In all cases, infiltration anaesthesia was per-
formed with 1% Ultracaín® 
With regard to the 26 patients who reported on the 
phone that they had bled and controlled the bleeding, 
the following extractions had been performed: 1 case 
of 4 extractions, 7 cases of 3 extractions (2 patients had 
stopped taking the antiplatelet therapy), 4 cases of 2 
extractions and 14 cases of just one tooth extraction (1 
patient had interrupted the antiplatelet therapy). Here a 
statistically significant difference was found (χ2=12.559, 
p=0.01).
Discussion
Over the last few years the recommendation has been 
to continue with the antiplatelet therapy during dental 
extractions (1-6), and we have worked along these lines 
in our study; the 14 patients who interrupted their an-
tiplatelet therapy did so on their own initiative, based on 
former beliefs and criteria,  and never by recommenda-
tion of the Oral Health Department professionals.
As part of the Navarre Health Service - Osasunbidea , the 
Oral Health Department operation is typical of that of 
any National Health System dental clinic. Patients come 
to the clinic of their own free will (or are referred by the 
Primary Care doctor, or by their private dentist) for a 
dental extraction for any type of pathology (7). Due to 
the fact that the patients in our study had a mean age of 
68.3 years, that there is no Clinical Analysis Laboratory 
at the centre in which the Oral Health Department is 
located, and that getting to the clinic is not always easy 
due to the geographical dispersion of the Community, 
we were obliged to dispense with performing a pre-ex-
traction analysis. This was further supported by the fact 
that there is no analytical test that serves to predict post-
extraction haemorrhages in those patients taking aspi-
rin as a antplatelet drug, as indicated by Brenan et al (1). 
Along these same lines, Aframian et al. (5) indicated 
that laboratory tests are not normally recommended for 
patients taking aspirin as an antiplatelet drug and who 
are to undergo dental extractions.
There is little literature referring to dental extractions 
in patients taking antiplatelet drugs, and the majority of 
the studies available exclusively, or almost exclusively, 
refer to the use of aspirin or acetylsalicylic acid (1-5). 
Although ASA is actually the most used antiplatelet 
drug (76.3% of the study patients), it can also be ob-
served that almost one quarter of our patients used a dif-
ferent antiplatelet drug, a circumstance which coincides 
with the observations of other authors (6). Whilst Ma-
rimoto et al. (6) indicate aspirin, ticlopidine, cilostazol 
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and dipiridamol in descending order of use of platelet 
antiplatelet drugs, in our study although ASA is also 
shown to be the most used drug, this is then followed by 
clopidogrel, triflusal and ticlopidine, as can be observed 
in Table 2. During our study, no particular antiplatelet 
drug was found to promote haemorrhages more than an-
other; neither were the different ASA dose levels seen 
to be associated with a higher or lower post-extraction 
haemorrhagic risk.
Of the works published to date on dental extractions in 
patients receiving antiplatelet therapy, this present study 
involves the highest number of patients.
Unlike other authors (3,6) we did not include tooth-
socket suturing as a means of achieving local haemos-
tasis, this is in line with the work of  Al-Mubarak et al. 
(8) who do not consider suture to be normally neces-
sary, only on a case by case basis and depending on the 
extension of the trauma. In our study, the wound was 
sutured for those patients undergoing surgical extrac-
tions.
At first sight, the results appear poor compared to other 
studies (6) which recorded 2.2% post-operative haem-
orrhages, or none at all in the case of other authors (3). 
However, our study was designed to record anything 
the patient considered to be anomalous as an anomaly, 
despite the fact that the application of a gauze pressure 
pack for a longer duration of time cannot really be con-
sidered anomalous, as occurred in 20 cases in which the 
patients simply applied a fresh dry gauze plug and which 
was sufficient to resolve the possible haemorrhage. This 
leaves just 5 cases, accounting for 3.2% of patients, of 
which only one patient actually went to A&E (0.6%), as 
the other 4 patients reported that they did the following: 
“rinses with water, vinegar and salt”, “the haemorrhage 
stopped by itself”, “it bled a little after 24 hours” and “it 
bled a little during the night”. In other words, the values 
for what could be considered to be an unexpected or 
uncontrolled haemorrhage are between 0.6 and 3.2%, 
which are closer to those values recorded for other stud-
ies.
We would underscore the fact that, amongst those pa-
tients applying a fresh dry gauze, 20 patients in all, 3 
had interrupted the antiplatelet therapy, an average of 
6 days before.
There is a clear relationship between the number of ex-
tractions in the same session and the subsequent haem-
orrhage, for which a statistically significant result was 
obtained; the more teeth removed the greater the risk of 
haemorrhage.
This present work reaffirms the fact that local measures 
are sufficient to control post-extraction haemorrhages 
in patients receiving antiplatelet therapy.
It seems advisable to be cautious with regard to the 
number of teeth to be extracted during the same ses-
sion. We would advise not extracting more than 3 teeth 
at a time, and that these should either be adjacent or 
correlative, not in different parts of the dental arch. For 
molar teeth, no more than two adjacent teeth should be 
extracted.
For further studies, the method to monitor or evaluate 
the post-operative haemorrhage should be refined.
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